Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04554147 · ClinicalTrials.gov registry record · NA
Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans
A NA study of High Blood Pressure, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 3
- Study locations
NCT04554147: Completed NA study of High Blood Pressure, sponsored by Mayo Clinic.
NCT04554147 is a NA study of High Blood Pressure that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 504-participant average among 23 other High Blood Pressure trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04554147, a NA study of High Blood Pressure, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 3
- Study locations
Study Summary
The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers.
Primary Outcome
Change from baseline blood pressure.
Conditions Studied
Interventions
- BEHAVIORAL FAITH! App-enhanced Hypertension Intervention
Study Locations (3)
Minnesota
- North Point Health & Wellness Center - Minneapolis
- Mayo Clinic - Rochester
- Open Cities Health Center - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT04554147 record still lists
NCT04554147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 504-participant average among 23 other High Blood Pressure trials with a reported enrollment target (97% lower).
The record links to 1 condition, with High Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which FAITH! App-enhanced Hypertension Intervention is the first listed.
NCT04554147 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04554147 about?
NCT04554147 is a clinical study titled "Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans". The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers.
What is the current status of trial NCT04554147?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-04-15. Estimated completion is 2023-06-30.
What conditions does trial NCT04554147 study?
This clinical trial studies the following conditions: High Blood Pressure.
What interventions are being tested in trial NCT04554147?
The interventions under investigation include: FAITH! App-enhanced Hypertension Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04554147?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04554147 being conducted?
This trial has 3 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04554147's enrollment target sits among peer trials
16 23rd of 23 higher than 1 of 23 other High Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other High Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Addressing Hypertension Care in Africa Program
RECRUITING · NA
-
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
RECRUITING · NA
-
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
RECRUITING · NA
-
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
RECRUITING · NA
-
CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
RECRUITING · NA
-
Delta GREENS Food is Medicine Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI